Off-label prescribing for children with chronic diseases in Nigeria; findings and implications

Kazeem Adeola Oshikoya1, Ibrahim Adekunle Oreagba2, Brian Godman3,4,5

  • 1a Pharmacology Department , Lagos State University College of Medicine , Lagos , Nigeria.

Insights

Off-label prescribing for pediatric epilepsy, asthma, and sickle cell anemia in Nigeria was studied. The overall rate of off-label prescriptions was found to be low, primarily related to dosage adjustments.

Area of Science:

  • Pediatric Pharmacology
  • Drug Utilization Studies
  • Global Health

Background:

  • Off-label medication use in children with chronic conditions is under-documented, particularly in developing nations.
  • This study addresses the need for data on pediatric prescribing practices in Nigeria.

Purpose of the Study:

  • To investigate the prevalence and patterns of off-label prescribing in Nigerian children with epilepsy, asthma, and sickle cell anemia.

Main Methods:

  • Retrospective review of prescriptions for children aged 16 years and younger.
  • Data collected from pediatric clinics in Lagos, Nigeria, between January and October 2015.
  • Utilized British National Formulary for children and American Hospital Formulary Service Drug information as references.

Main Results:

  • Out of 1746 prescriptions for 477 patients, 7.7% were off-label, predominantly due to dosage (68.9%).
  • Nervous system and anti-infective agents were most prescribed; off-label use was 9.5% and 8.2% respectively.
  • Children with epilepsy accounted for the majority of off-label prescriptions (69.6%).

Conclusions:

  • Off-label prescribing does occur in Nigerian children with epilepsy, asthma, and sickle cell anemia.
  • The overall rate of off-label prescribing in this population appears to be low.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K